T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 190 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04615468	A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）	unknown	Phase 2	78	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY	1	Nov 4, 2020	clinicaltrials
NCT03921879	Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma	unknown	Phase 1	50	Oncotartis, Inc.INDUSTRY	1	Oct 23, 2020	clinicaltrials